KP Biomedical Engineering - Issue #26

Happy International Women's Day!!!

"Greatest Thanks to all the women all around the world for their constant contributions to our Industry!"

-CommonWell Health Alliance Launches Healthcare Marketplace To Advance Interoperability BOSTON--(BUSINESS WIRE)

--CommonWell Health Alliance announced it is launching the CommonWell Marketplace, a platform designed to connect healthcare providers with innovative solutions that enhance interoperability and improve patient care. The Marketplace will serve as a one-stop shop for leading-edge technologies and services, empowering healthcare organizations to optimize their nationwide health data exchange priorities.

-Bunkerhill Health and Cleerly Announce Strategic Partnership to Advance Noninvasive Cardiovascular Care SAN FRANCISCO & DENVER--(BUSINESS WIRE)

--Bunkerhill Health, a leader in AI-enabled early disease detection, and Cleerly, a pioneer in advanced cardiovascular imaging, announced a strategic partnership to expand access to their technologies for coronary artery disease detection and risk assessment. The collaboration leverages both companies’ FDA-cleared solutions to help health systems identify at-risk patients earlier and deliver comprehensive cardiovascular care.

-Baxter Unveils Voalte Linq Device Powered by Scotty Assistant at HIMSS25 to Advance Voice-Activated Technology in Hospital Settings LAS VEGAS--(BUSINESS WIRE)

--Baxter International Inc. (NYSE:BAX), a global medtech leader, unveiled Voalte Linq device powered by Scotty assistant, the company’s first voice-activated technology, at the 2025 HIMSS Global Healthcare Conference. Voalte Linq, a lightweight, wearable badge, is powered by Scotty assistant, a voice-activated technology, to better enable efficient, streamlined communication between care teams, with the goal of freeing up more of their time and energy

-Allurion Announces Notification of Issuance of New U.S. Patents on Next-Generation Weight Loss Device for the Treatment of Obesity NATICK, Mass.--(BUSINESS WIRE)

--Allurion Technologies, Inc. (“Allurion” or the “Company”) (NYSE: ALUR), a company dedicated to ending obesity, announced that it has received two Issue Notifications from the U.S. Patent and Trademark Office (USPTO) dated February 19, 2025 for U.S. Patent No. 12,246,163 titled “Automatic-Sealing Balloon-Filling Catheter System” and U.S. Patent No. 12,245,962 titled “Balloon Sealing and Fill Valve”.

-ATEC Prices Upsized $350.0 Million Convertible Senior Notes Offering CARLSBAD, Calif.--(BUSINESS WIRE)

--Alphatec Holdings, Inc. (Nasdaq: ATEC), a provider of innovative solutions dedicated to revolutionizing the approach to spine surgery, announced the pricing of its offering of $350,000,000 aggregate principal amount of 0.75% convertible senior notes due 2030 (the “notes”) in a private offering to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the “Securities Act”).

-PESG Report: Inspira Technologies Breaks new Ground with Positive Clinical Data for AI-Powered Blood Sensor Exceeding Expectations NEW YORK--(BUSINESS WIRE)

--PESG Research releases an update following groundbreaking clinical evaluation results: Inspira Technologies* (NASDAQ: IINN) has reported exceptional clinical study outcomes for its HYLA blood sensor, with 96% accuracy achieved in a key parameter compared to traditional blood analyzers.

-Tivic Health Systems, Inc. Announces Reverse Stock Split FREMONT, Calif.--(BUSINESS WIRE)

--Tivic Health? Systems, Inc. (Nasdaq: TIVC) (“Tivic Health” or the “Company), a diversified therapeutics company, announced that its Board of Directors has declared a 1-for-17 reverse stock split of the Company’s issued and outstanding shares of common stock.

-Cerus Corporation Announces Receipt of CE Mark for Next-Generation INTERCEPT Illumination Device (INT200) CONCORD, Calif.--(BUSINESS WIRE)

--Cerus Corporation (Nasdaq: CERS) announced the CE mark approval of its next-generation LED-based illumination device, or the INT200, for the INTERCEPT Blood System for platelets and plasma under the European Union (EU) Medical Device Regulation (MDR). This approval allows Cerus to market the INT200 throughout the EU and in other regions that recognize the CE mark.

-QIAGEN receives U.S. clearance for second QIAstat-Dx mini gastrointestinal panel, expanding U.S. syndromic testing portfolio GERMANTOWN, Md. & VENLO, Netherlands--(BUSINESS WIRE)

--QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) announced that the U.S. Food and Drug Administration (FDA) has cleared the QIAstat-Dx Gastrointestinal Panel 2 Mini B for clinical use, further strengthening its syndromic testing portfolio in the United States.

-Rimkus Acquires Human Factors Consulting Services, Incorporated, Enhancing Expertise in Human Factors and Medical Device Consulting HOUSTON--(BUSINESS WIRE)

--Rimkus Consulting Group, Inc. (“Rimkus”), a premier global provider of engineering, technical consulting, and life sciences services, is pleased to announce the acquisition of Human Factors Consulting Services, Incorporated (“HFCSI”), a highly regarded firm specializing in proactive human factors services and medical device consulting.

-Openwater Announces New CEO as Demand for Portable Imaging and Non-Invasive Therapy Devices Accelerates SAN FRANCISCO--(BUSINESS WIRE)

--Openwater, the open-source medtech company delivering portable diagnostic and therapeutic devices at a fraction of typical costs, announces the appointment of Aaron Timm as Chief Executive Officer. As a former Vivalink executive with more than two decades in clinical leadership, Timm brings the strategic acumen and operational expertise to scale Openwater through its next phase of global growth.

-Trestle Bio Announces Research Collaboration with Humacyte SAN DIEGO--(BUSINESS WIRE)

--Trestle Biotherapeutics, Inc., announced a research collaboration with Humacyte, Inc. (Nasdaq: HUMA), a commercial-stage biotechnology platform company developing universally implantable, bioengineered human tissue at commercial scale. Trestle Bio is a preclinical stage company developing bioengineered kidney tissues for patients suffering from end stage renal disease (ESRD).

-Reflow Medical Expands Global Reach with New European Subsidiary SAN CLEMENTE, Calif.--(BUSINESS WIRE)

--Reflow Medical, Inc., a leading developer of innovative medical devices for complex cardiovascular disease, has announced the opening of its European subsidiary in Landsberg am Lech, Germany. This strategic expansion strengthens the company’s international presence and enhances its ability to serve markets outside the United States. Reflow Medical Europe GmbH is led by Senior Vice President and General Manager Knut Sauerteig.

-Innovative AI-enabled, low-cost device makes flow cytometry accessible for clinical use

--A team of researchers at the George R. Brown School of Engineering and Computing at Rice University has developed an innovative artificial intelligence (AI)-enabled, low-cost device that will make flow cytometry ? a technique used to analyze cells or particles in a fluid using a laser beam ? affordable and accessible.

-New three-organ system offers an animal-free alternative for pharmacokinetics research

--Innovative organ-on-chip specialist?Dynamic42?and?ESQlabs, experts in digital life sciences solutions, have successfully developed a three-organ system, in close collaboration with?Consumer Health Division of Bayer,?and the?Placenta Lab at Jena University Hospital.

-Tandem Health launches AI medical scribe to ease UK doctors' administrative burden

--The NHS and UK doctors are set to benefit from ground-breaking artificial intelligence technology designed to transform the way doctors interact with patients, reducing medical errors, cutting administrative burdens, and making thousands of additional appointments available.

-LabVantage Solutions unveils version 8.9 of its industry-leading LIMS platform to improve lab productivity and efficiency

--LabVantage Solutions, Inc., the leading provider of laboratory informatics solutions and services, announced the release of?LabVantage 8.9, the latest iteration of its flagship laboratory information management system (LIMS), to deliver the most cutting-edge capabilities to laboratories worldwide.

-New tool revolutionizes primer design for infectious disease detection

--Researchers from the Zhang Liye Laboratory have developed a groundbreaking tool that revolutionizes the way researchers design primers for detecting pathogens.

-Researchers train AI to read minds—by decoding brain signals into text

--Scientists have developed BrainLLM, a model that translates brain activity into natural language using fMRI and AI, outperforming previous classification-based methods.

-KAIST team develops framework for AI-based wearable blood pressure sensors

--A KAIST research team led by Professor Keon Jae Lee has proposed an innovative theoretical framework and research strategies for AI-based wearable blood pressure sensors, paving the way for continuous and non-invasive cardiovascular monitoring.

-TUM scientists develop new protein purification method using UV light

--Proteins play a key role in the life sciences - from basic research and biotechnological applications to the development and manufacturing of pharmaceuticals.

-WHO names Delft University of Technology as collaborating center for AI in health governance

--The World Health Organization (WHO)designated the Digital Ethics Centre at Delft University of Technology in the Netherlands as a WHO Collaborating Centre on artificial intelligence (AI) for health governance.